Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02153749
Other study ID # 1210010970
Secondary ID P50DA009241
Status Completed
Phase N/A
First received
Last updated
Start date September 2015
Est. completion date July 2019

Study information

Verified date April 2020
Source Yale University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators propose that brief training in regulation of craving may increase the efficacy of smoking cessation, but that training in cognitive vs. mindfulness-based strategies may operate via different psychological and neural mechanisms.


Description:

The investigators propose to test the efficacy of such training by randomizing 126 cigarette smokers to the following conditions: 1) brief training in cognitive regulation of craving 2) mindfulness-based training, and 3) control or no training. Training will be delivered in 6x1 hour computerized sessions over four weeks. Control subjects simply fill out assessments during their visits. Participants who were randomized into the cognitive or mindfulness training complete Regulation of Craving (ROC) training sessions of approximately 60-90 minutes. If randomized into the cognitive regulation training, subjects will be trained to use a cognitive strategy that instructs them to think of all the negative outcomes associated with continued cigarette smoking. If randomized into the MBT-based regulation training, subjects will be trained to use a mindfulness strategy that instructs them to notice and accept their feelings of craving without judgment or intent to act upon them. After all training sessions are completed, there is a 4 week and 12 week follow-up. The investigators will evaluate the effects of training on craving and regulation of craving measured by self-report and functional magnetic resonance imaging during the Regulation of Craving(ROC) task administered pre- and post- treatment, as well as smoking.


Recruitment information / eligibility

Status Completed
Enrollment 92
Est. completion date July 2019
Est. primary completion date July 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

1. Between the ages of 18 and 60

2. Smoking 10 or more cigarettes per day,

3. Score >4 on the Fagerstrom Test For Nicotine Dependence (FTND)

4. Treatment seeking (motivated to quit or reduce smoking; >6 on a 10 point likert scale)

5. Fluent English speaker

6. Can commit to the full length of the protocol (~8 weeks) and

7. Are willing to be randomized to treatment condition.

Exclusion Criteria:

1. Current or past comorbid Axis I disorders (assessed via the Mini Psychiatric Interview Diagnosis; MINI)

2. Current use of any psychoactive medications that have not been at a stable dose for the past 6 months, are used as mood stabilizers, or are used as smoking cessation treatments (e.g. varenicline).

3. Serious or unstable medical condition within past 6 months

4. Use of an investigational drug currently or within past 30 days

5. Use of psychoactive medications or those that affect blood flow

6. Other conditions contra-indicated for MRI (e.g., claustrophobia, presence of ferromagnetic metal in the body, prior head trauma with loss of consciousness, color blindness, hypertension, pregnancy).

7. For females only: pregnancy.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive Regulation of Craving
Regulation strategy practice: Participants will be trained to use a CBT-based cognitive regulation strategy. They will be asked to think of their individualized negative consequences for and thing of them when they see the instruction "LATER" during the task. Participants will practice using this strategy for multiple cigarette stimuli. High-Risk Situation Practice: Participants will identify 10 situations in which they usually smoke, or are likely to smoke in the next 48 hours. For each situation, they will be asked to practice using the strategy and to plan to use this strategy to regulate craving in daily life.
Mindfulness-Based Regulation of Craving
Each training session in this condition will be identical to the CBT-based training session described, with the exception of the strategy being trained. Specifically, participants will be trained in using the MBT-based strategy ("notice craving and accept the feeling without judgment or reaction"). To do so, they will be asked to generate their own non- reactive responses to craving (e.g., "I can just sit here and notice this. I can ask myself, 'can I be ok with this feeling?'") Participants will then be instructed to think of those accepting and non-reactive responses when they see the instruction "ACCEPT" during the task. All other components will be identical.

Locations

Country Name City State
United States Clinical & Affective Neuroscience Lab New Haven Connecticut

Sponsors (2)

Lead Sponsor Collaborator
Yale University National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

References & Publications (9)

Brewer JA, Mallik S, Babuscio TA, Nich C, Johnson HE, Deleone CM, Minnix-Cotton CA, Byrne SA, Kober H, Weinstein AJ, Carroll KM, Rounsaville BJ. Mindfulness training for smoking cessation: results from a randomized controlled trial. Drug Alcohol Depend. 2011 Dec 1;119(1-2):72-80. doi: 10.1016/j.drugalcdep.2011.05.027. Epub 2011 Jul 1. — View Citation

Carroll KM. Therapy Manuals for Drug Addiction. A Cognitive-Behavioral Approach: Treating Cocaine ?Addiction. In: Abuse NIoD, ed. Bethesda, MD: National Institute of Drug Abuse; 1998.

Elwafi HM, Witkiewitz K, Mallik S, Thornhill TA 4th, Brewer JA. Mindfulness training for smoking cessation: moderation of the relationship between craving and cigarette use. Drug Alcohol Depend. 2013 Jun 1;130(1-3):222-9. doi: 10.1016/j.drugalcdep.2012.11.015. Epub 2012 Dec 21. — View Citation

Ferguson SG, Shiffman S. The relevance and treatment of cue-induced cravings in tobacco dependence. J Subst Abuse Treat. 2009 Apr;36(3):235-43. doi: 10.1016/j.jsat.2008.06.005. Epub 2008 Aug 20. Review. — View Citation

Kober H, Kross EF, Mischel W, Hart CL, Ochsner KN. Regulation of craving by cognitive strategies in cigarette smokers. Drug Alcohol Depend. 2010 Jan 1;106(1):52-5. doi: 10.1016/j.drugalcdep.2009.07.017. Epub 2009 Sep 11. — View Citation

Kober H, Mende-Siedlecki P, Kross EF, Weber J, Mischel W, Hart CL, Ochsner KN. Prefrontal-striatal pathway underlies cognitive regulation of craving. Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14811-6. doi: 10.1073/pnas.1007779107. Epub 2010 Aug 2. — View Citation

Tang YY, Tang R, Posner MI. Brief meditation training induces smoking reduction. Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13971-5. doi: 10.1073/pnas.1311887110. Epub 2013 Aug 5. — View Citation

Westbrook C, Creswell JD, Tabibnia G, Julson E, Kober H, Tindle HA. Mindful attention reduces neural and self-reported cue-induced craving in smokers. Soc Cogn Affect Neurosci. 2013 Jan;8(1):73-84. doi: 10.1093/scan/nsr076. Epub 2011 Nov 22. — View Citation

Witkiewitz K, Bowen S, Douglas H, Hsu SH. Mindfulness-based relapse prevention for substance craving. Addict Behav. 2013 Feb;38(2):1563-71. doi: 10.1016/j.addbeh.2012.04.001. Epub 2012 Apr 6. Erratum in: Addict Behav. 2018 Mar 21;:. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Gender Whether gender moderates any of the findings 4 weeks
Primary Change in Self-report Craving level ROC task performance, as change from pre- to post- training in (1) craving (operationalized as self-reported craving on craving trials). (2) strategy-specific regulation (operationalized as scores on regulation trials using the trained strategy: LATER/control trials for CBT-based training, ACCEPT/mindfulness trials for MBT-based training). (3) strategy-non-specific regulation (scores on regulation - using the non-trained strategy: LATER trials for MBT-based training, ACCEPT trials for CBT-based training). Baseline to 4 weeks
Primary % change in craving and control related neural activity measured via functional magnetic resonance imaging (fMRI). The neural activity component will be calculated as change from pre-to post- training during fMRI ROC task, including (1) craving- related activity (operationalized as neural reactivity in "craving regions" including Ventral Striatum, ventral medial Pre-Frontal Cortex); (2) neural substrates of control during regulation of craving (operationalized as neural activity in "control regions" including dorsal lateral and ventral lateral prefrontal cortex). Baseline to 4 weeks
Primary Change in Smoking Measurement of reduction in cigarette smoking, measured by self report/cotinine/Carbon dioxide(CO2), and FTND smoking severity baseline to 4 weeks
Secondary Change in Cognitive Control & Affective Reactivity Behavioral Assessments Detection of generalized effects of the training on affective reactivity and cognitive control, including: (1) Distress Tolerance, (2) CANTAB neuropsychological assessments, and (3) Drug Risk Response Task (DRRT) to measure regulation skills acquisition. baseline to 4 weeks
Secondary Change in general neural activity measured via fMRI Determination if the effects of training generalize to other measures of cognitive control/distress tolerance, using fMRI task neural activity. Baseline to 4 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02643914 - Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings N/A
Recruiting NCT05530577 - Effects of Semaglutide on Nicotine Intake Phase 2
Withdrawn NCT05440721 - Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification N/A
Completed NCT03694327 - Innovative Digital Therapeutic for Smoking Cessation N/A
Completed NCT01944423 - Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine Early Phase 1
Completed NCT01704573 - Nicotinic Receptor Levels After Stopping Smoking N/A
Active, not recruiting NCT01015170 - STOP Study: Effectiveness of Zyban in a Clinical Population Phase 4
Completed NCT03281629 - Circuitry-Guided Smoking Cessation in Schizophrenia N/A
Recruiting NCT06291584 - Effects of Exercises on Functional Capacity N/A
Withdrawn NCT06259630 - Nicotine Virtual Reality Conditioned Place Preference Phase 4
Completed NCT02624284 - tDCS Effects on Resisting Smoking: Dose Ranging Study N/A
Active, not recruiting NCT02837510 - Neural Mechanisms Associated With Risk of Smoking Relapse N/A
Completed NCT02656745 - Clinical Trial of Smoking Cessation Mobile Phone Program N/A
Completed NCT01062932 - Investigation of Cycloserine as a Smoking Cessation Treatment Phase 1
Completed NCT03069482 - Feasibility Trial of a Tailored Smoking Cessation App for People With Serious Mental Illness Phase 1
Completed NCT02870218 - Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use Phase 2
Terminated NCT01756053 - Effects of ABT-089 on Smoking Abstinence Symptoms and Reward Phase 2
Completed NCT01252966 - Cognitive Training for Nicotine Dependence N/A
Active, not recruiting NCT04946825 - Quit Smoking Study for People Who Use E-Cigarettes Phase 2
Recruiting NCT05434429 - Mobile Health for Problematic Behaviors and Substance Use N/A